$16.49
+0 (+0%)
At Close: Jun 03, 2026
Best Growth Stocks to Buy for October 13th
07:31am, Friday, 13'th Oct 2023
PANW, SEM and LW made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 13, 2023.
Best Income Stocks to Buy October 13th
06:01am, Friday, 13'th Oct 2023
FANG, SEM and KUBTY made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 13, 2023.
Best Growth Stocks to Buy for October 10th
07:31am, Tuesday, 10'th Oct 2023
SEM, JELD and URBN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 10, 2023.
Pick These 4 Low P/CF Stocks to Uplift Your Portfolio
09:46am, Friday, 29'th Sep 2023
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Select Medical (SEM), EnerSys (ENS), Marathon Oil (MRO) and Adtalem Global (ATGE) boast a low P/CF
5 Low Price-to-Book Stocks Suitable for Value Investors
09:01am, Thursday, 28'th Sep 2023
The P/B ratio helps to identify low-priced stocks that have high growth prospects. Select Medical Holdings Corporation (SEM), Pampa Energia (PAM), Compania Cervecerias Unidas (CCU), Paysafe Limited (P
Are Investors Undervaluing Select Medical (SEM) Right Now?
11:16am, Thursday, 14'th Sep 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
5 Low Price-to-Book Stocks to Buy in September
09:46am, Thursday, 14'th Sep 2023
The P/B ratio helps to identify low-priced stocks that have high growth prospects. Select Medical Holdings Corporation (SEM), Office Properties Income Trust (OPI), KB Financial Group (KB), PagSeguro D
3 MedTech Stocks to Bet on Potential Pause of Rate Hike by Fed
09:02am, Friday, 01'st Sep 2023
Interest rates impact the healthcare industry and medical device companies in various ways. Here we discuss three companies HCA, ALC and SEM that are likely to gain potential pause in rate hikes.
Select Medical (SEM) Up 18% Year to Date: More Room to Run?
03:02pm, Thursday, 31'st Aug 2023
Select Medical (SEM) is well-poised for growth on the back of a credible healthcare facility portfolio built through buyouts and JVs coupled with strong cash-generating abilities.
5 Stocks With Attractive Price-to-Book Ratio Worth a Look
10:32am, Tuesday, 29'th Aug 2023
The P/B ratio helps to identify low-priced stocks that have high growth prospects. Select Medical Holdings Corporation (SEM), General Motors Company (GM), KB Financial Group (KB), StoneCo Ltd.
Is Select Medical (SEM) Stock Undervalued Right Now?
11:16am, Friday, 25'th Aug 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Select Medical (SEM) Q2 Earnings Meet, Revenues Rise Y/Y
01:32pm, Friday, 04'th Aug 2023
Select Medical's (SEM) Q2 results reflect solid segmental revenues, attributable to higher patient days and outpatient visits. Management projects adjusted EPS of $1.86-$2.03 for 2023.
Select Medical (SEM) Up 21% Year to Date: More Room to Run?
01:24pm, Friday, 14'th Jul 2023
Select Medical (SEM) is well-poised for growth on the back of improved patient volumes, an expanding healthcare portfolio and solid cash-generating abilities.
Select Medical (SEM) Q1 Earnings Top on Improving Profitability
12:09pm, Friday, 05'th May 2023
Select Medical (SEM) expects revenues to be within the range of $6.5-$6.7 billion in 2023, indicating a rise of 4.8% from the 2022 figure of $6.3 billion.
Select Medical (SEM) Q1 Earnings and Revenues Surpass Estimates
09:17pm, Thursday, 04'th May 2023
Select Medical (SEM) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.37 per share a year ago.
Sign In
Buy SEM